The Democratic Republic of Congo has been allocated 70,000 doses of Merck’s Ervebo vaccine for Ebola, the World Health Organization said on Thursday, as the country attempts to contain its biggest ever outbreak of the deadly disease. Here are some details: Last week Congo had requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group (ICG) on Vaccine Provision, according to WHO.

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to…

Imunizante aprovado mira a cepa Zaire, não a Bundibugyo

But it's not known if it will protect against the virus responsible for the current outbreak